News

Applied Clinical Trials Online22h

Dynavax Technologies’ Investigational Shingles Vaccine Achieves Complete Antibody Response in Phase I/II Shingles Trial

Results from the first part of a Phase I/II trial (NCT06569823) showed that Z-1018 generated immune responses comparable to ...
Applied Clinical Trials Online22h

DEI & Clinical Trials: Navigating Policy Shifts

This explainer unpacks how recent US policy shifts are reshaping diversity, equity, and inclusion in clinical research, ...